Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2026-05-06 20:00:33 ET · period of report 2026-05-04 · accession 0001506916-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-06 20:00 | 2026-05-04 | TVTX | Meckler Jeffrey A | Dir | M - OptEx | $16.33 | +8,000 | 95.5K | +9% | +$130.6K |
| DT | 2026-05-06 20:00 | 2026-05-04 | TVTX | Meckler Jeffrey A | Dir | S - Sale+OE | $45.00 | -8,000 | 87.5K | -8% | -$360.0K |
| DT | 2026-05-06 20:00 | 2026-05-04 | TVTX | Meckler Jeffrey A | Dir | M - OptEx | $0.00 | -8,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-04 | M | A | 8,000 | $16.33 | 95,500 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-04 | S | D | 8,000 | $45.00 | 87,500 | D | — | — | (F1) This sale was made pursuant to a written plan adopted on November 17, 2025 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option granted to the Reporting Person on May 18, 2016 with an expiration date of May 18, 2026. |
| 3 | Derivative | Stock option (right to buy) | 2026-05-04 | M | D | 8,000 | $0.00 | 0 | D | $16.33 · — to 2026-05-18 | 8,000 Common Stock | (F2) The stock option is fully vested and exercisable. |